A synthetic bbb-permeable tripeptide gcf confers neuroprotection by increasing glycine in the ischemic brain

HIGHLIGHTS

• who: BBB and collaborators from the Hebei University of Science and Technology, China have published the research work: A synthetic BBB-permeable tripeptide GCF confers neuroprotection by increasing glycine in the ischemic brain, in the Journal: (JOURNAL)
• what: The authors showed that glycine had low BBB permeability in ischemic conditions.
• how: The results showed that the treatment of GCF (150 mg/kg) increased the level of glycine in the ischemic brain tissue at 40 60 80 100 and 120 min after GCF injection while compared with the vehicle group . The data showed that . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.